WT
BIIB icon

Wilmington Trust’s Biogen BIIB Stock Holding History

Wilmington Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$5.12M Buy
16,225
+5,708
+54% +$1.72M 0.09% 154
2014
Q1 		$3.22M Buy
10,517
+162
+2% +$51.4K 0.06% 192
2013
Q4 		$2.9M Sell
10,355
-380
-4% -$98.3K 0.05% 210
2013
Q3 		$2.58M Buy
10,735
+229
+2% +$51.3K 0.05% 212
2013
Q2 		$2.26M Buy
+10,506
New +$2.24M 0.05% 219

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wilmington Trust's BIIB Position: Q2 2014 in Review

Wilmington Trust increased its Biogen (BIIB) stake by 54% in Q2 2014, buying an estimated $1.72M and bringing the position to 16,225 shares worth $5.12M. The position accounts for 0.09% of the portfolio, ranked #154.

Wilmington Trust first reported a position in BIIB in Q2 2013 and has held it in 5 quarters since. 782 funds tracked by Wall St. Rank hold BIIB as of Q2 2014.

  • Wilmington Trust held 16,225 shares of Biogen worth $5.12M as of Q2 2014.
  • Wilmington Trust bought 5,708 Biogen shares in Q2 2014, an estimated $1.72M.
  • Biogen made up 0.09% of Wilmington Trust's portfolio in Q2 2014, its #154 holding.
  • Wilmington Trust first reported a position in Biogen in Q2 2013 and has held it in 5 quarters since.
  • 782 funds tracked by Wall St. Rank held Biogen as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.